876 - Sustained Long-Term Efficacy and Safety of RPC4046, an Anti-Interleukin-13 Monoclonal Antibody, in Patients with Eosinophilic Esophagitis: Results from the Open-Label Extension of the Heroes Study
Authors:
- Evan S. DellonEDEvan S. Dellon
- Margaret H. CollinsMCMargaret H. Collins
- Yehudith Assouline-DayanYAYehudith Assouline-Dayan
- Larry EvansLELarry Evans
- Sandeep K. GuptaSGSandeep K. Gupta
- Alain M. SchoepferASAlain M. Schoepfer
- Alex StraumannASAlex Straumann
- Ekaterina SafroneevaESEkaterina Safroneeva
- Amy WooAWAmy Woo
- Allan OlsonAOAllan Olson
- Gregory OpiteckGOGregory Opiteck
- Richard ArandaRARichard Aranda
- 1 May 2018
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 154 (6) , S-174-174